Asthma drug shortens COVID-19 recovery time
Budesonide, a drug used to treat asthma, has been found to shorten recovery time in COVID-19 patients who are treated at home.
US stops Johnson & Johnson vaccine to investigate blood clot risk
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
After COVID, can we better manage and prevent the likely rise in elderly falls?
Barak Katz, VP and GM Essence SmartCare, discusses the future of fall prevention and establishing more proactive elderly care, post COVID-19.
One in four HIV patients experience intimate partner violence
According to the CDC, one in four HIV patients in the United States experience intimate partner violence - which could be anything between physical assault to stalking.
Why does the U.S. need an STI National Strategic Plan?
Open Access Government discusses STI prevention in the U.S., and the benefits and priorities of the STI National Strategic Plan 2021-2025.
A long-term collaborative approach to addressing health inequality
Christine Hancock, Founder and Director at C3 Collaborating for Health, discusses the ongoing issue of health inequality that COVID-19 has exposed, and how to ensure healthy lives for all.
Norway’s healthcare sector: Prioritising digital solutions in 2021
Open Access Government discuss how the Norwegian Minister for Health and Care Services, Bent Høie has navigated his ministries response to the COVID-19 crisis, and his priorities for 2021.
Center for Disease Control says surfaces “low-risk” for COVID transmission
New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.
A year with COVID-19: What has healthcare learnt?
Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.
1 in 10 suffer long-term effects 8 months after mild COVID-19 infection
According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.
Healthy under-30s should take alternative vaccine to AstraZeneca
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
Breast milk may protect babies against COVID-19
A new study by Washington University School of Medicine suggests that breastfeeding mothers may pass protective COVID-19 antibodies to their babies through breast milk for at least 80 days following vaccination.
Moderna COVID vaccine rollout begins in UK
The Moderna COVID vaccine will initially be given to patients in Wales - which brings the UK up to three approved vaccines.
A vision for a healthier European Union
Open Access Government explores the health priorities of Stella Kyriakides, Commissioner for Health and Food Safety, asking if lessons learned from the ongoing COVID-19 pandemic can help to improve European healthcare?.
What are the symptoms of digital eye strain and how can it be treated?
Dr Deborah Lee, Dr Fox Online Pharmacy, highlights the symptoms of digital eye strain and explains what can be done to treat it.
HealthTracker™ for patients, clinician & researchers
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
How can touch-free technology help the NHS?
Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.
A healthcare system for the 21st century
Ben Howlett, Managing Director at Public Policy Projects, discusses why we must invest in technology to enable our healthcare systems to reform, and the role of technology in facilitating collaboration between service providers.
Data shows 49% of Black British adults want COVID vaccine
ONS data from January shows that only 49% of Black British adults would take the COVID vaccine - the UK Government acknowledges that others are wary about the intention of "some institutions and authorities".
Data finds 36% of people refuse COVID vaccine due to side effect fears
According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
